IMCCB-25 aspires to bring together a diverse assembly of leading researchers, clinicians, industry professionals, and other experts and opinion leaders from around the world.

The conference will cover a broad spectrum of topics, including basic and clinical methodologies, safety, analytics, pharmaceutics, regulatory and legal considerations, pharmacological insights, and technological advancements. Emphasis is on practical implications for patients, researchers, medical persons, and industry leaders alike. Additional topics include palliative care, women medicine, psychiatry and geriatric diseases, niche indications as well as non-medical cannabis use disorders.

IMCCB-25 seeks to inform participants about the latest evidence and concepts regarding cannabis- and cannabinoid-based therapies. It aims to assist prescribers in practically implementing best practices based on current research, expert opinions and therapy guidelines. Furthermore, the conference provides a unique platform for the exchange of ideas and practices in medical cannabis among professionals and patients, fostering innovative and engaging discussions.

IMCCB-25 will be held February 13-14, 2025 at the University of Bern, Switzerland. For more information visit: https://www.imccb.org/